email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2637-4544

Interventions in Gynaecology and Women's Healthcare

Research Article(ISSN: 2637-4544)

Preeclampsia Predictability Tools using Trace Metal Screening and Angiogenic Markers is Clinically Valuable

Volume 3 - Issue 5

Ayman El-Dorf1* and Maha M Hagras2

  • Author Information Open or Close
    • 1Obstetrics and Gynecology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
    • 2Clinical Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt

    *Corresponding author: Ayman El Dorf, Obstetrics and Gynecology Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Received:September 03, 2019;   Published: September 30, 2019

DOI: 10.32474/IGWHC.2018.03.000175

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Background: Preeclampsia at molecular and cellular levels was observed as a disease of placentation that is affected by interaction of various factors that could trigger the disease pathological course and behavior. Prenatal environmental metals exposure is considered a cornerstone factor that could trigger the clinical presentation of preeclampsia due to toxic effects of some trace metals, besides the deficiency of some trace elements is considered a crucial issue in cell apoptosis and remodeling is one of the characteristic features of trophoblastic invasion.

Aim: To investigate the predictability value of trace metal screening in predictability of preeclampsia clinical development.

Methodology: The current research clinical trial is prospective in manner that recruited 420 research study subjects from January 2017 till April 2019 ,inclusive research criteria were singleton gestations with no congenital fetal anomalies all recruited research study subjects had full clinical history taking and examination during antenatal visits urinary samples obtained during 10th till 15th gestational weeks were assessed for the trace metal profile investigated and angiogenic markers. Urine samples were collected at 10th till 15th gestational weeks and stored at − 80 °C until analysis after delivery, preeclampsia diagnosis and diagnosis date were abstracted from medical records. Preeclampsia was clinically defined as elevated maternal blood pressure (>140mmHg systolic and/or >90mmHg diastolic) and proteinuria (>300 mg/24 h or a protein/creatinine ratio >0.20) after 20 gestational weeks.

Results: Cr chromium at Cut off point >0.92 have AUC= 0.747, statistical Sensitivity= 80.0, statistical Specificity=60.8, PPV=13.6, NPV =97.5, Se selenium at cutoff point ≤ 35.4 have AUC= 0.759, statistical Sensitivity=83.3, statistical Specificity=62.6, PPV=14.6, NPV =98.

Conclusion: The current study provokes the clinical value for trace metal screening in detectability of preeclamptic risk of development, however future research efforts are requiring correlating the clinical risk of disease development according to the environmental trace metal levels.

Abstract| Introduction| Methodology| Urinary Trace Metals Analysis| Plasma Biomarkers of Angiogenesis| Statistical Analysis| Results| Discussion| Conclusion and Recommendations for Future Research| References|